4//SEC Filing
Huang James 4
Accession 0000950170-25-097087
CIK 0001604464other
Filed
Jul 20, 8:00 PM ET
Accepted
Jul 21, 9:00 AM ET
Size
7.1 KB
Accession
0000950170-25-097087
Insider Transaction Report
Form 4
Huang James
Director10% Owner
Transactions
- Purchase
Common Stock
2025-07-17$9.64/sh+19,335$186,372→ 1,350,000 total(indirect: See Footnotes)
Panacea Innovation Ltd
10% Owner
Transactions
- Purchase
Common Stock
2025-07-17$9.64/sh+19,335$186,372→ 1,350,000 total(indirect: See Footnotes)
Footnotes (2)
- [F1]Represents securities held by Panacea Venture Healthcare Fund II, L.P.
- [F2]James Huang is the sole owner of Panacea Innovation Limited, which is the sole owner of Panacea Venture Healthcare Fund II GP Company, Ltd. ("Fund II GP") and Panacea Opportunity Fund I GP Company, Ltd. ("Opportunity Fund GP"), which are the general partners of Panacea Venture Healthcare Fund II, L.P. and Panacea Opportunity Fund I, L.P. As a result, each of the Reporting Persons may be deemed to share beneficial ownership of the securities held of record by Panacea Venture Healthcare Fund II, L.P. and Panacea Opportunity Fund I, L.P., but each disclaims such beneficial ownership.
Documents
Issuer
Atara Biotherapeutics, Inc.
CIK 0001604464
Entity typeother
Related Parties
1- filerCIK 0001573160
Filing Metadata
- Form type
- 4
- Filed
- Jul 20, 8:00 PM ET
- Accepted
- Jul 21, 9:00 AM ET
- Size
- 7.1 KB